SOUTH SAN FRANCISCO, Calif. , Nov. 12, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc.
(NASDAQ: IDYA ), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the Jefferies London Healthcare Conference and its plans to host an Investor R&D Day in December 2024 . Jefferies London Healthcare Conference Tuesday, November 19 th , 2024 at 10:00 AM GMT | 5:00 AM ET Fireside chat with Yujiro S. Hata , Chief Executive Officer, hosted by Maury Raycroft , Ph.
D. Equity Research Analyst, Biotechnology IDEAYA Biosciences Investor R&D Day Monday, December 16 th , 2024 at 8:00 AM ET The IDEAYA Investor R&D Day will highlight IDEAYA's potential first-in-class preclinical and clinical pipeline with management, leading Key Opinion Leader(s) (KOLs), and Pharma partner(s) Pre-registration will be available through IDEAYA's investor relations events page at https://ir.ideayabio.
com/events , or https://lifescievents.com/event/ideaya-4/ A live audio webcast of the conference event, as permitted by the conference host, will be available at the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.
com/events and/or through the conference host. A replay of the webcast will be accessible for 30 days following the live event. About IDEAYA Biosciences IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using mo.
